跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 68,903 条关于
“PD-1 antibody”
全部
68,903
临床试验
39,870
药物
9,434
机构
1,432
资讯
18,167
2年前
Camrelizumab Shows Promise in Initially Unresectable NSCLC
6个月前
Junshi Biosciences Achieves Regulatory Milestone with First Domestic Subcutaneous Anti-PD-1 Antibody Application in China
2年前
Akeso's Bispecific Antibodies Show Promise in Lung and Colorectal Cancers
8个月前
Ottimo Pharma Receives FDA Clearance for First-in-Class Dual PD-1/VEGFR2 Antibody OTP-01
10个月前
Crescent Biopharma Advances PD-1 x VEGF Bispecific Antibody CR-001 Toward Phase 1 Trial
8个月前
AbbVie Secures $5.6 Billion Licensing Deal for Novel PD-1/VEGF Bispecific Antibody RC148
去年
Merck Expands Oncology Pipeline with $3.2B Deal for LaNova's Bispecific Antibody
去年
FDA Approves IND for FP008, a Novel PD-1×IL-10M Fusion Protein for Resistant Solid Tumors
去年
LaNova Medicines Initiates Phase 1 Trial of LM-299, Anti-PD-1/VEGF Bispecific Antibody, for Advanced Solid Tumors
2年前
Akeso Initiates Phase III Trial of Cadonilimab Bispecific Antibody for PD-L1 Negative NSCLC
第 1 页,共 1817 页
上一页
下一页